APA (7th ed.) Citation

G, T., SP, H., A, K., L, S., P, G., T, P., & C, T. (2013). Pharmaco-economic analysis of direct medical costs of metastatic colorectal cancer therapy with XELOX or modified FOLFOX-6 regimens: Implications for health-care utilization in Australia. Asia-Pacific journal of clinical oncology, 9(3), 239. https://doi.org/10.1111/ajco.12044

Chicago Style (17th ed.) Citation

G, Tran, Hack SP, Kerr A, Stokes L, Gibbs P, Price T, and Todd C. "Pharmaco-economic Analysis of Direct Medical Costs of Metastatic Colorectal Cancer Therapy with XELOX or Modified FOLFOX-6 Regimens: Implications for Health-care Utilization in Australia." Asia-Pacific Journal of Clinical Oncology 9, no. 3 (2013): 239. https://doi.org/10.1111/ajco.12044.

MLA (9th ed.) Citation

G, Tran, et al. "Pharmaco-economic Analysis of Direct Medical Costs of Metastatic Colorectal Cancer Therapy with XELOX or Modified FOLFOX-6 Regimens: Implications for Health-care Utilization in Australia." Asia-Pacific Journal of Clinical Oncology, vol. 9, no. 3, 2013, p. 239, https://doi.org/10.1111/ajco.12044.